JGP Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,510
Closed -$246K 151
2020
Q4
$246K Buy
+1,510
New +$193K 0.06% 130

Other funds holding XBI

JGP Wealth Management's XBI Position: Q1 2021 in Review

JGP Wealth Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2021, closing a stake of 1,510 shares — an estimated $246K sold.

JGP Wealth Management first reported a position in XBI in Q4 2020 and held it in 1 quarter. The position peaked at $246K in Q4 2020. 644 funds tracked by Wall St. Rank hold XBI as of Q1 2021.

  • JGP Wealth Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2021 after selling out during the quarter.
  • JGP Wealth Management sold 1,510 State Street SPDR S&P Biotech ETF shares in Q1 2021, an estimated $246K.
  • JGP Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and held it in 1 quarter.
  • JGP Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $246K in Q4 2020.
  • 644 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2021.

Based on JGP Wealth Management's 13F filing for Q1 2021, filed 28 Apr 2021.